Written by expert consultants and clinical scientists currently practising in the UK, the BSH Guidelines provide up-to-date evidence-based guidance on the diagnosis and treatment of haematological diseases.

For those with slower machines or internet connections, please see our plain text version of the Guidelines listing.

You will find three styles of guideline:

BSH Guideline (previously known as BCSH Guidelines)
Evidence-based guideline developed following a professional literature search and a review of the evidence by the writing group.

BSH Good Practice Paper 
Used to recommend good practice in areas where there is a less robust evidence base but for which a degree of consensus or uniformity is likely to be beneficial to patient care.

BSH Position Paper 
The adoption and adaptation of a non-UK evidence-based guideline for use in the UK.

Join BSH to get advance previews and to input into Guidelines via our "sounding board".

See the list of archived BSH Guidelines or modify your communications preferences to receive up-to-date news and information on BSH Guidelines.

The copyright for the guidelines and the material in the guidelines (which includes the text, tables, photographs, images and figures) is owned by Wiley. For the avoidance of doubt, you must not reproduce any part of the guidelines without prior permission from Wiley.   You may request permission to use the copyright materials in these guidelines by emailing permissions@wiley.com

Please note that we cannot provide clinical advice on the guidelines to members of the public.

If you have any suggestions for new guidelines or have any guideline enquiries please contact Rita Gupta (Guidelines Programme Manager) by email bshguidelines@b-s-h.org.uk

Haematology Oncology Task Force Vacancy

The Haematology-Oncology Task Force of the British Society for Haematology Guidelines (BSH Guidelines) requires one new member.

The appointments will be for 3 years in the first instance. Applications are requested from consultant haematologists or clinical scientists involved in Haemato-Oncology. You will need to be working in a UK hospital and interested in joining the Task Force.

The Task Force meets three times annually via Zoom Video Conferencing. The work of the taskforce is mostly in producing and updating guidelines and addressing other areas of development relevant to the UK. Being part of this group offers an excellent opportunity to help advance a career.

To register your interest please send your CV and covering letter to Rita Gupta, BSH Guidelines Programme Manager: rita@b-s-h.org.uk by Monday, 31 May 2021.

Guidelines Committee Vice Chair Vacancy

The British Society for Haematology Guidelines Committee requires a new Vice Chair from July 2021. The appointment is for 2 years leading on to the position of Chair of the BSH Guidelines Committee from July 2023.

Applications are requested from BSH members who are currently, or have been in the last three years, members of one of the BSH Guidelines Task Forces.

The Guidelines Committee meets 3 times annually either by zoom or at the BSH offices in London. The work of the Vice Chair is:

• To act as deputy for the Chair when required
• To co-ordinate along with the Chair, guideline production providing clear guidance to Task Force Chairs to ensure due process
• To attend meetings with other organisations EHA/ ASH

To register your interest please send your CV and covering letter to Rita Gupta, BSH Guidelines Programme Manager: rita@b-s-h.org.uk by 31 May 2021.

Guidelines Session ASM Videos available for viewing

To access the Guidelines Session presentations from the 2019 Annual Scientific Meeting in Glasgow please follow the link below.


You will need to log in as a BSH member to view them. 

Join as a BSH member

The following presentations given during the Guidelines Session with link to the BSH Guideline are below:

Use of viscoelastic haemostatic assays in the management of major bleeding - Dr Nikki Curry

Diagnosis and therapy of genetic haemochromatosis - Dr Edward Fitzsimons

Use of hydroxycarbamide in children and adults with sickle cell disease - Dr Amrana Quereshi